Intraperitonealadministration of telmisartan inhibited diabetes and glucose-induced retinalexpression of ICAM-1 and VEGF, and upregulation of ICAM-1 and MCP-1, viainhibition of nuclear translocation of NF-κB [33]. Here, ICAM1 is linked to diabetes mellitus.